Methotrexate Induced Lung Toxicity-A Case Report

[1] In patients with medication-induced lung toxicity, the radiologic patterns are highly variable and it rely upon the sort of antagonistic response the patient is experiencing. Since the vast majority of the medication prompted lung toxicities like the interstitial infiltrates, parenchyma may migh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Research journal of pharmacy and technology 2017-10, Vol.10 (10), p.3458-3460
Hauptverfasser: Lekshmi, S Sandhya, Antony, Remya, Sidharthan, Neeraj, Kammath, Gireesh, Anila, K. N
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3460
container_issue 10
container_start_page 3458
container_title Research journal of pharmacy and technology
container_volume 10
creator Lekshmi, S Sandhya
Antony, Remya
Sidharthan, Neeraj
Kammath, Gireesh
Anila, K. N
description [1] In patients with medication-induced lung toxicity, the radiologic patterns are highly variable and it rely upon the sort of antagonistic response the patient is experiencing. Since the vast majority of the medication prompted lung toxicities like the interstitial infiltrates, parenchyma may might be exhibited on radiographs. [3] Major criteria are as follows: * Hypersensitivity pneumonitis in view of histopathology, without confirmation of pathogenic organisms * Radiologic evidence of alveolar or pulmonary interstitial infiltrates. * Negative blood cultures (if febrile) and initial sputum cultures (if sputum is produced) Minor criteria are as follows: * Cough that are non-productive * Shortness of breath for < 2 months * During initial evaluation, Oxygen saturation < 90% on room air. * DLCO < 70% of predicted * < 15,000 cells/pL of leukocyte count There are very few studies in similar occurrence. In this case study, patient showed better clinical presentation after the cessation of the culprit, high dose methotrexate, Prompt diagnosis is vital in cases like above, in light of the fact that early medication-induced lung damage will frequently relapse with the end of treatment. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports:
doi_str_mv 10.5958/0974-360X.2017.00617.5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2048070483</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2048070483</sourcerecordid><originalsourceid>FETCH-LOGICAL-c198t-e597c9402f55977c36b701f3dcf0651b53a095ef208a98e74021d9b6df6fd6743</originalsourceid><addsrcrecordid>eNo9kFtLxDAQhYMouKz7F6Tgc-ukaW6PS_GyUBFkBd9CmybaRduapLD77013ZefhzIE5zDAfQrcYMiqpuAfJi5Qw-MhywDwDYFHpBVqcB5dnj8U1Wnm_g1hM0LwQCwQvJnwNwZl9HUyy6dtJmzappv4z2Q77TnfhkK6TsvYmeTPj4MINurL1tzer_75E748P2_I5rV6fNuW6SjWWIqSGSq5lAbml0XFNWMMBW9JqC4zihpIaJDU2B1FLYXhM4lY2rLXMtowXZInuTntHN_xOxge1GybXx5Mqh0IAj0Jiip1S2g3eO2PV6Lqf2h0UBjUDUvPvauagZkDqCEhR8gfCGVay</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2048070483</pqid></control><display><type>article</type><title>Methotrexate Induced Lung Toxicity-A Case Report</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Lekshmi, S Sandhya ; Antony, Remya ; Sidharthan, Neeraj ; Kammath, Gireesh ; Anila, K. N</creator><creatorcontrib>Lekshmi, S Sandhya ; Antony, Remya ; Sidharthan, Neeraj ; Kammath, Gireesh ; Anila, K. N</creatorcontrib><description>[1] In patients with medication-induced lung toxicity, the radiologic patterns are highly variable and it rely upon the sort of antagonistic response the patient is experiencing. Since the vast majority of the medication prompted lung toxicities like the interstitial infiltrates, parenchyma may might be exhibited on radiographs. [3] Major criteria are as follows: * Hypersensitivity pneumonitis in view of histopathology, without confirmation of pathogenic organisms * Radiologic evidence of alveolar or pulmonary interstitial infiltrates. * Negative blood cultures (if febrile) and initial sputum cultures (if sputum is produced) Minor criteria are as follows: * Cough that are non-productive * Shortness of breath for &lt; 2 months * During initial evaluation, Oxygen saturation &lt; 90% on room air. * DLCO &lt; 70% of predicted * &lt; 15,000 cells/pL of leukocyte count There are very few studies in similar occurrence. In this case study, patient showed better clinical presentation after the cessation of the culprit, high dose methotrexate, Prompt diagnosis is vital in cases like above, in light of the fact that early medication-induced lung damage will frequently relapse with the end of treatment. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports:</description><identifier>ISSN: 0974-3618</identifier><identifier>EISSN: 0974-360X</identifier><identifier>EISSN: 0974-306X</identifier><identifier>DOI: 10.5958/0974-360X.2017.00617.5</identifier><language>eng</language><publisher>Raipur: A&amp;V Publications</publisher><subject>Acids ; Case reports ; Chemotherapy ; Cytotoxicity ; Drug dosages ; Fever ; Immune system ; Infections ; Lung diseases ; Lymphoma ; Orthopedics ; Patients ; Pneumonia ; Rheumatoid arthritis ; Tomography</subject><ispartof>Research journal of pharmacy and technology, 2017-10, Vol.10 (10), p.3458-3460</ispartof><rights>Copyright A&amp;V Publications Oct 2017</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c198t-e597c9402f55977c36b701f3dcf0651b53a095ef208a98e74021d9b6df6fd6743</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Lekshmi, S Sandhya</creatorcontrib><creatorcontrib>Antony, Remya</creatorcontrib><creatorcontrib>Sidharthan, Neeraj</creatorcontrib><creatorcontrib>Kammath, Gireesh</creatorcontrib><creatorcontrib>Anila, K. N</creatorcontrib><title>Methotrexate Induced Lung Toxicity-A Case Report</title><title>Research journal of pharmacy and technology</title><description>[1] In patients with medication-induced lung toxicity, the radiologic patterns are highly variable and it rely upon the sort of antagonistic response the patient is experiencing. Since the vast majority of the medication prompted lung toxicities like the interstitial infiltrates, parenchyma may might be exhibited on radiographs. [3] Major criteria are as follows: * Hypersensitivity pneumonitis in view of histopathology, without confirmation of pathogenic organisms * Radiologic evidence of alveolar or pulmonary interstitial infiltrates. * Negative blood cultures (if febrile) and initial sputum cultures (if sputum is produced) Minor criteria are as follows: * Cough that are non-productive * Shortness of breath for &lt; 2 months * During initial evaluation, Oxygen saturation &lt; 90% on room air. * DLCO &lt; 70% of predicted * &lt; 15,000 cells/pL of leukocyte count There are very few studies in similar occurrence. In this case study, patient showed better clinical presentation after the cessation of the culprit, high dose methotrexate, Prompt diagnosis is vital in cases like above, in light of the fact that early medication-induced lung damage will frequently relapse with the end of treatment. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports:</description><subject>Acids</subject><subject>Case reports</subject><subject>Chemotherapy</subject><subject>Cytotoxicity</subject><subject>Drug dosages</subject><subject>Fever</subject><subject>Immune system</subject><subject>Infections</subject><subject>Lung diseases</subject><subject>Lymphoma</subject><subject>Orthopedics</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>Rheumatoid arthritis</subject><subject>Tomography</subject><issn>0974-3618</issn><issn>0974-360X</issn><issn>0974-306X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo9kFtLxDAQhYMouKz7F6Tgc-ukaW6PS_GyUBFkBd9CmybaRduapLD77013ZefhzIE5zDAfQrcYMiqpuAfJi5Qw-MhywDwDYFHpBVqcB5dnj8U1Wnm_g1hM0LwQCwQvJnwNwZl9HUyy6dtJmzappv4z2Q77TnfhkK6TsvYmeTPj4MINurL1tzer_75E748P2_I5rV6fNuW6SjWWIqSGSq5lAbml0XFNWMMBW9JqC4zihpIaJDU2B1FLYXhM4lY2rLXMtowXZInuTntHN_xOxge1GybXx5Mqh0IAj0Jiip1S2g3eO2PV6Lqf2h0UBjUDUvPvauagZkDqCEhR8gfCGVay</recordid><startdate>20171001</startdate><enddate>20171001</enddate><creator>Lekshmi, S Sandhya</creator><creator>Antony, Remya</creator><creator>Sidharthan, Neeraj</creator><creator>Kammath, Gireesh</creator><creator>Anila, K. N</creator><general>A&amp;V Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>04Q</scope><scope>04S</scope><scope>04W</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20171001</creationdate><title>Methotrexate Induced Lung Toxicity-A Case Report</title><author>Lekshmi, S Sandhya ; Antony, Remya ; Sidharthan, Neeraj ; Kammath, Gireesh ; Anila, K. N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c198t-e597c9402f55977c36b701f3dcf0651b53a095ef208a98e74021d9b6df6fd6743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acids</topic><topic>Case reports</topic><topic>Chemotherapy</topic><topic>Cytotoxicity</topic><topic>Drug dosages</topic><topic>Fever</topic><topic>Immune system</topic><topic>Infections</topic><topic>Lung diseases</topic><topic>Lymphoma</topic><topic>Orthopedics</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>Rheumatoid arthritis</topic><topic>Tomography</topic><toplevel>online_resources</toplevel><creatorcontrib>Lekshmi, S Sandhya</creatorcontrib><creatorcontrib>Antony, Remya</creatorcontrib><creatorcontrib>Sidharthan, Neeraj</creatorcontrib><creatorcontrib>Kammath, Gireesh</creatorcontrib><creatorcontrib>Anila, K. N</creatorcontrib><collection>CrossRef</collection><collection>India Database</collection><collection>India Database: Business</collection><collection>India Database: Science &amp; Technology</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Research journal of pharmacy and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lekshmi, S Sandhya</au><au>Antony, Remya</au><au>Sidharthan, Neeraj</au><au>Kammath, Gireesh</au><au>Anila, K. N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methotrexate Induced Lung Toxicity-A Case Report</atitle><jtitle>Research journal of pharmacy and technology</jtitle><date>2017-10-01</date><risdate>2017</risdate><volume>10</volume><issue>10</issue><spage>3458</spage><epage>3460</epage><pages>3458-3460</pages><issn>0974-3618</issn><eissn>0974-360X</eissn><eissn>0974-306X</eissn><abstract>[1] In patients with medication-induced lung toxicity, the radiologic patterns are highly variable and it rely upon the sort of antagonistic response the patient is experiencing. Since the vast majority of the medication prompted lung toxicities like the interstitial infiltrates, parenchyma may might be exhibited on radiographs. [3] Major criteria are as follows: * Hypersensitivity pneumonitis in view of histopathology, without confirmation of pathogenic organisms * Radiologic evidence of alveolar or pulmonary interstitial infiltrates. * Negative blood cultures (if febrile) and initial sputum cultures (if sputum is produced) Minor criteria are as follows: * Cough that are non-productive * Shortness of breath for &lt; 2 months * During initial evaluation, Oxygen saturation &lt; 90% on room air. * DLCO &lt; 70% of predicted * &lt; 15,000 cells/pL of leukocyte count There are very few studies in similar occurrence. In this case study, patient showed better clinical presentation after the cessation of the culprit, high dose methotrexate, Prompt diagnosis is vital in cases like above, in light of the fact that early medication-induced lung damage will frequently relapse with the end of treatment. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports:</abstract><cop>Raipur</cop><pub>A&amp;V Publications</pub><doi>10.5958/0974-360X.2017.00617.5</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0974-3618
ispartof Research journal of pharmacy and technology, 2017-10, Vol.10 (10), p.3458-3460
issn 0974-3618
0974-360X
0974-306X
language eng
recordid cdi_proquest_journals_2048070483
source EZB-FREE-00999 freely available EZB journals
subjects Acids
Case reports
Chemotherapy
Cytotoxicity
Drug dosages
Fever
Immune system
Infections
Lung diseases
Lymphoma
Orthopedics
Patients
Pneumonia
Rheumatoid arthritis
Tomography
title Methotrexate Induced Lung Toxicity-A Case Report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T09%3A40%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methotrexate%20Induced%20Lung%20Toxicity-A%20Case%20Report&rft.jtitle=Research%20journal%20of%20pharmacy%20and%20technology&rft.au=Lekshmi,%20S%20Sandhya&rft.date=2017-10-01&rft.volume=10&rft.issue=10&rft.spage=3458&rft.epage=3460&rft.pages=3458-3460&rft.issn=0974-3618&rft.eissn=0974-360X&rft_id=info:doi/10.5958/0974-360X.2017.00617.5&rft_dat=%3Cproquest_cross%3E2048070483%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2048070483&rft_id=info:pmid/&rfr_iscdi=true